ASP Isotopes Inc. announced that it has entered into a definitive securities purchase agreement to issue 8,459,093 shares at a price of $0.9105 per share for the gross proceeds of $7,702,004.1765, 1,190,239 shares at a price $0.9548 for the gross proceeds of $1,136,440.1972 and 303,178 shares at a price $0.96 for the gross proceeds of $291,050.88 for the total gross proceeds of $9,129,495.2537 on October 9, 2023. The transaction will include participation from returning investor Tees River Critical Resources Fund Limited, and multiple members of the company?s board of directors. As a part of the transaction, the company may a fee equal to 5.0% of the aggregate gross proceeds from the shares sold that is $456,474.7626.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.11 USD | -5.89% | -5.89% | +185.47% |
05-15 | ASP Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-10 | ASP Isotopes Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+185.47% | 265M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- ASPI Stock
- News ASP Isotopes Inc.
- ASP Isotopes Inc. announced that it expects to receive $9.129495 million in funding from Tees River Critical Resources Fund Limited